Results
Displaying results 41 to 60 out of 329
Filters
![](https://www.rhsupplies.org/typo3temp/assets/images/79141517e4.png)
Published in 2023
The Importance of Political Economy Analysis for Strengthening Health Commodity Supply Chains: A Primer
USAID Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/58bb8452d4.png)
Published in 2023
Helping Mothers Survive Bleeding After Birth Complete: ACTION PLAN
USAID Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/c08d9c2b50.png)
Published in 1994
An Assessment of the need for contraceptive introduction in Brazil
WHO Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/2579c95238.png)
Published in 2009
PRODOPS Professional Development Opportunities for Public Sector Reproductive Health Commodity Managers - Final Activity Report
RHSC: General RHSC: Innovation Fund
![](https://www.rhsupplies.org/typo3temp/assets/images/570e8a3664.png)
Published in 2022
Ley Cenabast y anticoncepción: información y beneficios para consumidoras
RHSC: General
![](https://www.rhsupplies.org/typo3temp/assets/images/b9bb0f8752.png)
Published in 2022
Médicaments pour la prévention et le traitement de l’hémorragie du post-partum et d’autres indications obstétricales
RHSC: General USAID Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/c41240cab8.png)
Published in 2009
Atteindre les OMDs: La contribution de la planification familiale: Burkina Faso
RHSC: General
![](https://www.rhsupplies.org/typo3temp/assets/images/9cccb43f1a.png)
Published in 2004
Processes and Issues for Improving Access to Medicines- The evidence base for domestic production and greater access to medicines
DFID Health Resource Centre
![](https://www.rhsupplies.org/typo3temp/assets/images/bf1cef305c.png)
Published in 2009
Contraceptive Security in Nigeria: Assessing Strengths and Weaknesses
DELIVER Country Report DELIVER Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/ec4a0e4bd6.png)
Published in 2004
Access to Medicines in Under-served Markets: What are the implications of changes in intellectual property rights, trade and drug registration policy?
DFID Health Resource Centre